Curis, Inc. (CRIS)
0.603
+0.01
(+2.01%)
USD |
NASDAQ |
Apr 17, 16:00
0.60
0.00 (0.00%)
Pre-Market: 08:27
Curis SG&A Expense (Quarterly) : 2.883M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 12.30M |
| Plus Therapeutics, Inc. | 4.168M |
| Windtree Therapeutics, Inc. | 1.855M |
| Halozyme Therapeutics, Inc. | 77.03M |
| AIM ImmunoTech, Inc. | 1.87M |